Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fNIRS mechanism of IPT and antidepressants in depression
NCT05927129Unknown
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jan 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD) (3 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Changes in fNIRS (functional Near-Infrared Spectroscopy) at 12 weeks and Change in remission rate of Hamilton Depression Scale (24-items) at 12 weeks. Status: unknown.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05927129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05927129.